- Patient/Guest
- Phlebotomist
- Updates
| GTT 2 Samples | - |
|---|
|
Measure glucose tolerance |
||
| Synonym | See updates | |
| Test Code | CDBIOPR0012 | |
| Test Type | Biochemistry | |
| Pre-Test Condition | See updates | |
| Report Availability | 1 D(s) | |
| # Test(s) | Multiple | |
| Test details | Sample Report |
|---|---|
| GTT 2 Samples |
|
| Synonym | See updates | ||
| Test Code | CDBIOPR0012 | ||
| Test Category | Diabetes | ||
| Pre-Test Condition | See updates | ||
| |
Medical History | See updates | |
| Report Availability | 1 D(s) | ||
| Specimen/Sample | Serum; 2 mL; SST | ||
| Stability @21-26 deg. C | 6 Hr(s) | ||
| Stability @ 2-8 deg. C | 7 D(s) | ||
| Stability @ Frozen | 1 M(s) | ||
| # Test(s) | Multiple | ||
| Processing Method | Spectrophotometry | ||
| **Glucose Tolerance Test OGTT 75 gm glucose 2 samples fasting and 2 hrs****FDA Status**: Standard laboratory procedure under CLIA; no specific FDA approval required.**Other Names**: OGTT 2-Hour Test, Diabetes Test.**Historical Breakthrough**: Developed in the 1960s to diagnose diabetes, advancing endocrinology.**Key Purpose and Impact**: Measures fasting and 2-hour glucose after 75g glucose load to diagnose diabetes or prediabetes.**Preparation and Patient History**: Fasting blood, then 75g glucose; report polyuria, thirst, or diabetes history.**Consent Requirement**: Standard consent for diagnostic testing.**Clinical Value**: Sensitivity ~95%; specificity ~95%; detects diabetes in ~90% of cases; guides therapy.**References Cited**: Testing.com Diabetes Tests 2023; Labcorp OGTT Test 2025; UpToDate Diabetes Diagnosis 2025 |
